High rates of inducible clindamycin resistance among prenatal group B streptococcal isolates in one northwest Louisiana academic medical center

CDC guidelines for prevention of perinatal group B Streptococcus (GBS) infections ([1][1]), which recommended universal screening and intrapartum antibiotic prophylaxis (IAP) for pregnant women colonized with GBS or with risk factors that increased intrapartum transmission of GBS, decreased the rate